Nanopharmaceutics
Manufacturing · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
14120 NW 126th Ter, Alachua, Florida, 32...Phone Number
(386) 319-6266Website
www.nanopharmaceutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Nanopharmaceutics
Nanopharmaceutics, Inc. focuses on discovering and developing targeted therapeutic products aimed at treating cancer, central nervous system disorders, and infectious diseases. The company offers a variety of products including Triapine, ATTM, and NanoBUP among others. Their intended clients include healthcare providers and patients in need of effective treatment options. Nanopharmaceutics operates under the umbrella of TRON Group Inc.Explore more
Nanopharmaceutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nanopharmaceutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Nanopharmaceutics recently announced quarterly report
Product Launch: Get notified when Nanopharmaceutics launches new products
Funding: Get notified immidiatlly once Nanopharmaceutics has new funding data
Click to see if Nanopharmaceutics had a recent Job posting/layoffs
Nanopharmaceutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Nanopharmaceutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Nanopharmaceutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Nanopharmaceutics
Recommended Actions
Reach out to Masked Content who joined Nanopharmaceutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Nanopharmaceutics
Compare insights from companies similar to Nanopharmaceutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nanopharmaceutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nanopharmaceutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nanopharmaceutics.
Nanopharmaceutics Tech Stack
A closer look at the technologies used by Nanopharmaceutics
Nanopharmaceutics News & Media
Nanopharmaceutics Inc. Announces Initiation of Clinical Study of Triapine + Radiation for Glioblastoma or Astrocytoma
Initiation of Clinical Study Testing the Addition of an Anti-Cancer Drug, Triapine®, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma TRON Group Inc. (OTCMKTS:TGRP) ALACHUA, FL, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- …Nanopharmaceutics and Northwestern University Announce Initiation of Phase I Adaptive Dose Escalation Clinical Study with Dose Expansion of Oral Triapine® in Combination with Temozolomide (TMZ) for Patients with Recurrent Glioblastoma
ALACHUA, Fla. and CHICAGO, May 14, 2024 /PRNewswire/ -- Nanopharmaceutics, Inc. (OTC:TGRP), a clinical-stage pharmaceutical development company, announced the initiation of a Phase I clinical study with the Robert H. Lurie Comprehensive Cancer Center of Northwestern University "A Phase 1...Nanopharmaceutics, Inc. Announces the End of Patient Recruitment for the National Cancer Institute (NCI) Sponsored Phase 3 Clinical Study in Advanced-Stage Cervical and Vaginal Cancers with Cisplatin During Radiation Therapy with and without Triapine®
ALACHUA, Fla., Nov. 2, 2022 /PRNewswire/ -- Nanopharmaceutics, Inc., a clinical-stage pharmaceutical development company, today announced completion of patient enrollment in the 450 patient Phase 3 clinical study sponsored by the NCI, part of the National Institutes of Health, and led by...TRON Group, Inc. and Nanopharmaceutics, Inc. Announce Definitive Merger Agreement
EAGLE, Idaho and ALACHUA, Fla., Aug. 11, 2022 /PRNewswire/ -- TRON Group, Inc. (OTC PINK: TGRP) ("TRON" or "the Company") and Nanopharmaceutics, Inc. ("Nano"), a privately-held clinical-stage pharmaceutical development company incorporated in Florida, announced today the signing of a...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nanopharmaceutics
Sign Up For FreeTo access detailed company insights
Nanopharmaceutics, Inc. focuses on discovering and developing targeted therapeutic products aimed at treating cancer, central nervous system disorders, and infectious diseases. The company offers a variety of products including Triapine, ATTM, and NanoBUP among others. Their intended clients include healthcare providers and patients in need of effe... Read More
